Jim Simons
TLSI icon

Jim Simons’s TriSalus Life Sciences TLSI Stock Holding History

Jim Simons’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,900
Closed -$124K – 3608
2026
Q1 		$124K Buy
+30,900
New +$151K ﹤0.01% 2999
2025
Q2 		– Sell
-20,200
Closed -$112K – 3900
2025
Q1 		$112K Buy
20,200
+6,800
+51% +$36.2K ﹤0.01% 3179
2024
Q4 		$67.1K Buy
+13,400
New +$56.6K ﹤0.01% 3345

Other funds holding TLSI

First Light Asset Management
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.7B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Jim Simons's TLSI Position: Q2 2026 in Review

Jim Simons sold out of TriSalus Life Sciences (TLSI) in Q2 2026, closing a stake of 30,900 shares — an estimated $124K sold.

Jim Simons first reported a position in TLSI in Q4 2024 and held it in 3 quarters. The position peaked at $124K in Q1 2026. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Jim Simons reported no remaining TriSalus Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Jim Simons sold 30,900 TriSalus Life Sciences shares in Q2 2026, an estimated $124K.
  • Jim Simons first reported a position in TriSalus Life Sciences in Q4 2024 and held it in 3 quarters.
  • Jim Simons's TriSalus Life Sciences position peaked at $124K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.